GeneDesign joins Ajinomoto Bio-Pharma BioPharma-Reporter.com
The Ajinomoto subsidiary opens a development and production base for oligonucleotide drug substances in Japan. GeneDesign, Japanese contract …
Original published: 2019-04-23 14:51:00 Read the full Osaka News here
Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.